Total Return chart Precigen, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-20 pm EDT			5-day change	1st Jan Change
4.110 ^USD	+3.27%		-1.44%	-1.67%

Apr. 07	Precigen Expects Q1 Revenue to Surpass $18 Million Due to Strong Uptake of Recurrent Respiratory Papillomatosis Drug	MT
Apr. 07	(PGEN) Precigen Expects Q1 Revenue to Exceed $18M, vs. FactSet Est of $20.8M	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

2015-06-08

0.162203 USD